China Healthwise Holdings Limited provided consolidated earnings guidance for the year ended 31 December 2023. The Group expects to record a loss attributable to owners of the Company within a range of approximately HKD 134 million to HKD 138 million of the Company as compared to a loss attributable to owners of the Company of approximately HKD 54 million for the year ended 31 December 2022 ("Fiscal year 2022"). The expected increase in loss is mainly due to increase in the impairment loss in respect of loan receivables from approximately HKD 25 million in financial year 2022 to approximately HKD 107 million in financial year 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.063 HKD | +5.00% | +21.15% | +53.66% |
Mar. 26 | China Healthwise Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 21 | China Healthwise to Widen Losses in 2023 | MT |
1st Jan change | Capi. | |
---|---|---|
+53.66% | 6.2M | |
+17.35% | 71.39B | |
+5.38% | 8.59B | |
+6.69% | 8.19B | |
-20.96% | 7.91B | |
+0.49% | 4.54B | |
+17.12% | 4.31B | |
-3.38% | 3.93B | |
-2.61% | 3.86B | |
+22.08% | 3.64B |
- Stock Market
- Equities
- 348 Stock
- News China Healthwise Holdings Limited
- China Healthwise Holdings Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2023